文献速递心力衰竭与心肌病

随机心力衰竭试验中中心裁定与研究者报告结局的比较

Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials.
PubMed 文献 · Eur Heart J · 2024-01-01

该研究利用七项纳入中心裁定心衰结局的心血管结局试验数据,比较研究者报告与中心裁定事件的一致性、裁定阳性与阴性心衰事件后全因死亡风险,以及基于两种事件来源的对数风险比相关性。结果显示心衰住院裁定阳性率低于心血管死亡,但阴性裁定心衰事件仍具预后意义;中心裁定未改变对数风险比的估计精度或结果,但存在一定变异。

要点

  • 心衰住院的中心裁定阳性率(61.6%-88.0%)低于心血管死亡(87.9%-99.2%)。
  • 裁定阴性心衰住院后的全因死亡风险与裁定阳性者相似。
  • 中心裁定与研究者报告的对数风险比在心血管死亡和复合终点相关性好,心衰住院相关性较弱。

核心结论

  • 心衰事件裁定阳性率低于心血管死亡,但阴性裁定心衰事件仍具预后重要性。
  • 中心裁定未改变对数风险比的估计精度或结果,但根据适应症存在一定变异。
  • 特定试验是否进行心衰事件中心裁定可能需要个体化决策。

研究设计与样本

  • 利用七项纳入中心裁定心衰结局、患者数>1000的心血管结局试验数据。
  • 评估研究者报告与中心裁定心衰及心血管死亡事件的一致性。
  • 分析裁定阳性与阴性心衰事件后全因死亡率。
  • 比较基于中心裁定与研究者报告事件的对数风险比相关性。

主要发现

  • 研究者报告事件的裁定阳性率跨试验差异大,心血管死亡为87.9%-99.2%,心衰住院为61.6%-88.0%。
  • 裁定阳性与阴性心衰住院后的全因死亡风险相似。

临床怎么用

  • 心内科医生解读心衰试验时,应知晓心衰事件裁定阳性率可能较低。
  • 阴性裁定心衰事件仍提示预后不良,临床不应忽视。
  • 中心裁定对主要疗效估计影响有限,试验设计可个体化考虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Heart failure endpoints in cardiovascular outcome trials are commonly identified through centralized adjudication of investigator-reported events. It remains unclear whether central adjudication improves the accuracy of treatment effect estimates in terms of log[hazard ratios (HR)]. METHODS: Data from seven cardiovascular outcome trials with >1000 patients that included centrally adjudicated heart failure outcomes were utilized to assess (i) the concordance between investigator-reported and centrally adjudicated heart failure and cardiovascular death events; (ii) rates of subsequent all-cause mortality following positively vs. negatively adjudicated heart failure events; and (iii) the correlation of log(HR) based on centrally adjudicated vs. investigator-reported events. RESULTS: Positive adjudication rates for investigator-reported events varied widely across trials, but were generally higher for cardiovascular death (range: 87.9%-99.2%) than for heart failure hospitalization (range: 61.6%-88.0%). The risk for subsequent all-cause death was similar for positively and negatively adjudicated heart failure hospitalizations. Log(HR) correlated well for cardiovascular death [R2 = .80, 95% credible interval (CrI): 0.53-0.93] and the composite of cardiovascular death or heart failure hospitalization (R2 = .79, 95% CrI: 0.46-0.93), but less for heart failure hospitalization (R2 = .57, 95% CrI: 0.10-0.83). CONCLUSIONS: Positive adjudication rates were lower for heart failure events than cardiovascular death, but even negatively adjudicated heart failure events are prognostically important. Central adjudication of events did not alter the results (precision or estimated log(HR)), though some variation was observed, depending on the indication. The results suggest that the decision to pursue centralized adjudication of heart failure events in a specific trial may need to be individualized.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Wandel, Desai, Chen, et al. Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials. Eur Heart J. 2024. PMID: 39515836. doi:10.1093/eurheartj/ehae753

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。